Skip to main content

Table 3 HIV related clinical characteristics of the study participants by nutritional status (N = 350)

From: Nutritional status and the associated factors among people living with HIV: an evidence from cross-sectional survey in hospital based antiretroviral therapy site in Kathmandu, Nepal

Variable

N (%)

Nutritional status

p value

Underweight

N = 64

Normal

N = 149

Overweight/Obese

N = 137

 

ART regimen

    

0.17

 Non-zidovudine based regimen

215 (61.4)

39 (18.1)

84 (39.1)

92 (42.8)

 

 Zidovudine based regimen

135 (38.6)

25 (18.5)

65 (48.1)

45 (33.3)

 

ART duration Median (range)

48 (6, 168)

0.12

 ≥ 24 months

234 (66.9)

49 (20.9)

100 (42.7)

85 (36.3)

 

 <  24 months

116 (33.1)

15 (12.9)

49 (42.2)

52 (44.8)

 

Opportunistic infection

    

0.15

 No

338 (96.6)

61 (18.0)

143 (42.3)

134 (39.6)

 

 HCV

7 (2.0)

0 (0.0)

5 (71.4)

2 (28.6)

 

 Tuberculosis

4 (1.1)

2 (50.0)

1 (25.0)

1 (25.0)

 

 Syphilis

1 (0.3)

1 (100.0)

0 (0.0)

0 (0.0)

 

WHO stage

    

0.04

 Stage I

153 (43.7)

21 (13.7)

64 (41.8)

68 (44.4)

 

 Stage II

81 (23.1)

25 (30.9)

32 (39.5)

24 (29.6)

 

 Stage III

80 (22.9)

13 (16.3)

36 (45.0)

31 (38.8)

 

 Stage IV

36 (10.3)

5 (13.9)

17 (47.2)

14 (38.9)

 

CD4 count Median (range)

 

368.5 (13, 1713)

382 (5, 1468)

440 (21, 1695)

0.69

 Less than 200 cells/mm3

51 (14.6)

12 (23.5)

20 (39.2)

19 (37.3)

 

 Between 200 to 500 cells/mm3

176 (50.3)

34 (19.3)

75 (42.6)

67 (38.1)

 

 Greater than 500 cells/ mm3

123 (35.1)

18 (14.6)

54 (43.9)

51 (41.5)

 

Hemoglobin level

    

0.02

 Non-anemic

238 (68)

38 (16.0)

92 (38.7)

108 (45.4)

 

 Anemic

112 (32)

26 (23.2)

57 (50.9)

29 (25.9)